Objective: A randomised double-blind placebo controlled withdrawal clinical trial of prednisone versus placebo in patients with rheumatoid arthritis (RA), treated in usual clinical care with 1–4 ...

The healthcare provider would then gradually taper the 4-mg dose. People on long-term prednisone therapy have the greatest risk for withdrawal symptoms. However, it can occasionally affect people who ...

Diffuse proliferative lupus nephritis was diagnosed by renal biopsy and she was treated with one pulse of cyclophosphamide (500 mg) and oral prednisone (60 mg/day). Three days later she developed ...

Results—After eight weeks of treatment, remission occurred in 60% of patients receiving budesonide ... administered at 9 mg once daily or 4.5 mg twice daily, is comparable to prednisolone in inducing ...

Methods Patients were randomised to double-blind MR prednisone (taken at approximately 22:00) or IR prednisone (taken in the morning), 15 mg/day for 4 weeks. The primary end point was complete ...

[1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR-BHPR guidelines suggesting an initial prednisone dose comprised between 15 and 20 mg as appropriate. [2] However ...

The aim of this study is to test if 12.5 mg prednisone/day is an adequate starting dose in PMR and to evaluate clinical predictors of drug response. Methods: 60 consecutive PMR patients were ...

26 27 Model-based estimates determined fosdagrocorat superiority of ≥20% versus placebo, with ≥80% confidence (ie, lower bound of 60% credible interval ≥20%) and fosdagrocorat non-inferiority to ...

Factors associated with recurrence in a multivariable analysis included younger age (60 years and older versus younger than ...